Treating Peripheral Arterial Disease After Revascularization : Episode 2

Video

November 11, 2021

PAD Comorbidities

Marc Bonaca, MD, MPH, and Sonia Anand, MD, PhD, explain the comorbidities that increase patient risk for PAD.

EP: 1.Pathophysiology of Peripheral Arterial Disease

EP: 2.PAD Comorbidities

EP: 3.Incidence and Clinical Manifestations of PAD

EP: 4.Costs of Major Atherothrombotic Vascular Events in PAD After Revascularization

EP: 5.Advances in PAD Management: CAPRIE and DAPT Trials

EP: 6.Advances in PAD Management: EUCLID and COMPASS Trials

EP: 7.Advances in PAD Management: VOYAGER Trial

EP: 8.Antithrombotic Therapy in the PAD Post-Vascularization Setting

EP: 9.VOYAGER PAD Trial

EP: 10.Current Treatment Algorithms for PAD

EP: 11.Unmet Needs in PAD

EP: 12.Key Takeaways for Vascular Physicians

Related Videos

Discussing 140-Week Data on Upadacitinib for Atopic Dermatitis, with Raj Chovatiya, MD, PhD

Mohammad Abuassi, MD | Credit: ACG

Remo Panaccione, MD | Credot: ACG

HCPLive CKD and CVD NewsNetwork Thumbnail

HCPLive CKD and CVD NewsNetwork Thumbnail

HCPLive CKD and CVD NewsNetwork Thumbnail

HCPLive CKD and CVD NewsNetwork Thumbnail

HCPLive CKD and CVD NewsNetwork Thumbnail

Looking Deeper into Genetic Variants of FSGS, with Jennifer Lai Yee, MD, PhD, MPH

Abdul Abdellatif, MD: More Gout Education Needed for Nephrologists

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.